- We will send in 10–14 business days.
/images/books/11383730/9781608055197.jpg)
- Author: Marc Chamberlain
- Publisher: Bentham Science Publishers
- ISBN-10: 1608055191
- ISBN-13: 9781608055197
- Format: 21.6 x 27.9 x 1.4 cm, softcover
- Language: English
- SAVE -10% with code: EXTRA
Reviews
Description
Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This book presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of avastin's role in restricting malignant gliomas is also included giving readers a diverse perspective on the rationale of treating CNS tumors.
EXTRA 10 % discount with code: EXTRA
The promotion ends in 20d.14:27:39
The discount code is valid when purchasing from 10 €. Discounts do not stack.
- Author: Marc Chamberlain
- Publisher: Bentham Science Publishers
- ISBN-10: 1608055191
- ISBN-13: 9781608055197
- Format: 21.6 x 27.9 x 1.4 cm, softcover
- Language: English English
Neuro-oncology is an embryonic field of cancer research with a number of clinical trials in progress. However, the prognosis on neuro-oncologic patients has remained poor. Moreover, several small scale phase I/II trials performed have proved to be inconclusive because of the limited number of patients involved. As a result, many controversies exist in neuro-oncology drug development for which a forum does not exist. This book presents a detailed account on the use of avastin in treating cancer patients. A discussion on clinical experiences and the controversial debate among researchers of avastin's role in restricting malignant gliomas is also included giving readers a diverse perspective on the rationale of treating CNS tumors.
Reviews